All Posts

Stomach paralysis. The two words put together sound terrifying. The testimony about people who experienced stomach paralysis is enough to make you think twice about taking a GLP-1 like Ozempic, Wegovy, Mounjaro, and Zepbound. Some people describe feeling full after only a few bites, while others report severe nausea or vomiting that doesn't seem to go away. Even painful bloating and insufferable heartburn come into the conversation. So is stomach paralysis a real risk with G

I've noticed a common thread running through many of the GLP-1 forums and social media groups I follow. Women are getting pregnant while taking medications like Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Trulicity, and Victoza. In many cases, the posts start the same way: "We'd been trying for years." "I thought I couldn't get pregnant." "I was waiting to start fertility treatment." Then comes the surprise positive pregnancy test. The phenomenon has become common enough th

Two million people get married each year, according to the CDC. GLP-1 usage (Ozempic, Wegovy, Zepbound, etc.) stands at around 40 million users. When those two statistics meet, it can cause additional anxiety around wedding dress selection, deadlines, timelines, and more. It's not new that a bride or groom wants to look their best during their wedding week. What is new is the change in the obesity and weight loss landscape brought on by the GLP-1 revolution. Rapid weight loss

The race to develop effective oral GLP-1 medications for obesity is heating up, and AstraZeneca is officially making its move. If you're like me, that means you're also seeing hope that the out-of-pocket costs of these medications, which include Ozempic, Zepbound, and Wegovy, will go down in the future as more players enter the field. At the 2026 American Diabetes Association Scientific Sessions, AstraZeneca announced positive Phase 2b results for elecoglipron. The medication

If you've suddenly started hearing the word snatiation online, you can thank former Blossom star and neuroscientist Mayim Bialik. In a recent essay detailing her difficult experience with a GLP-1 medication, Bialik described an unexpected symptom that sent many people running to Google: "sneezing attacks every time I tried to eat or drink." The symptom has a name. It's called snatiation, a combination of the words "sneeze" and "satiation." The unusual reflex causes some peopl

I often joke that my life experiences better prepared me for a nuclear attack, massive earthquake, and financial collapse of the U.S. banking system than they did for menopause awareness. If you're like me, menopause can feel like a bit of a body betrayal. The habits that worked for decades suddenly stop producing results. The number on the scale creeps upward despite eating the same foods. Belly fat seems to appear out of nowhere. Energy levels change. Sleep becomes unpredic

Nobody understands the fear of GLP-1 injections more than I do. Taking a medication like Ozempic, Wegovy, or Zepbound is intimidating enough. Add in a fear of needles and the idea of giving yourself a shot, and it's enough to make many people pause, even after spending hundreds of dollars out of pocket. I get it. When I started this journey, the shot was one of the biggest hurdles. Today, after more than a year of weekly injections, I could probably give myself a shot with my

If you've started a GLP-1 medication and feel too exhausted to exercise, you're not alone. I hear it all the time from readers. I've experienced it myself as the biggest side effect of Zepbound over the past 18 months. There have been days when I barely had enough energy to sit upright and hold a conversation, much less hit the recommended number of cardio sessions and strength workouts for the week. Fatigue is one of the most commonly reported side effects of GLP-1 medicati

When most people start a GLP-1 medication like Zepbound, Wegovy, Ozempic, or Mounjaro, they become experts at tracking numbers. Weight loss? Tracked. Protein intake? Noted. Carbs, calories, sugar, water, steps, workouts, sleep? Check, Check, Check . But there's one number many people never measure until months into their journey, and by then, some of the damage may already be done. I'm talking about muscle mass. The uncomfortable truth about GLP-1 medications is that they don

To avoid burying the lead, yes, everyone who has the insurance or financial means to do so should get a DEXA scan before starting a GLP-1. The older you are, the more important a DEXA scan becomes if you're thinking of taking Wegovy, Zepbound, Foundayo, or Ozempic. While many of the side effects and benefits of GLP-1s are evident, you won't be able to keep as close an eye on the bone and muscle impacts of these medications. If there's one thing I wish I could go back and do b

If you've spent any time in GLP-1 groups, you've probably seen people talking about collagen supplements. Some swear by them for skin, hair, nails, and joints. Others argue they're a waste of money. The truth falls somewhere in the middle. Collagen can be a helpful addition to your routine, especially during significant weight loss. But there's one detail many people miss: collagen and vitamin C are a team. Taking one without the other may limit the benefits you're hoping to

When most people think about rapid weight loss, they expect changes in their clothes, energy levels, blood pressure, or even loose skin. Few expect their ears to get involved. Did you even know your ears had fat that could put your hearing at risk? Some people who lose a significant amount of weight report a strange collection of symptoms: hearing their own voice echo loudly in their head, feeling like an ear is constantly "open," hearing their breathing inside their ear, or

When I started taking Zepbound, I quickly realized something. The bathroom scale was only telling part of the story. Sure, the number was going down. That was great. But what was actually happening inside my body? Was I losing fat? Muscle? Water? A little of everything? That's when I bought a smart scale. Like many people on a GLP-1 journey, I wanted more data than a simple weight measurement could provide. Smart scales promise insights into body fat percentage, muscle mass,

For years, my future seemed pretty straightforward. At some point, I was going to need a knee replacement. I have bone-on-bone osteoarthritis in both knees. Every orthopedic appointment seemed to end with the same conversation. The surgery wasn't necessarily needed today, but it was coming eventually. The only question was when. To further complicate and concern my health, my mother passed away after her second knee replacement surgery. Blood clots entered her lungs the day a

If you’re a Medicare beneficiary interested in weight-loss medications like Wegovy, Zepbound, or Foundayo, the Medicare GLP-1 Bridge could be a game-changer. I know I've gotten many questions from Medicare recipients about how to get into the GLP-1 revolution. This new, short-term demonstration program launched by the Centers for Medicare & Medicaid Services (CMS) gives eligible Medicare Part D beneficiaries access to certain GLP-1 medications for just $50 per month. What Is

My journey on Zepbound entered maintenance mode recently. After losing the bulk of the weight that was impacting my health, I finally hit that magic number (and healthy BMI). I can eat whatever I want without side effects, though "what I want" is notably lower than it was two years ago. At the same time, I noticed I can only stomach food once a day. Is that healthy? I remember once doing a tour of a pioneer farm in a random Midwest town. They were explaining that without refr

GLP-1 medications like semaglutide and tirzepatide have become popular for weight loss and diabetes management, but many people are also asking a new question: how do GLP-1s affect mood? I even saw on The Today Show they referred to it as "Ozempic Personality." Research suggests the answer is not one-size-fits-all. Some people report feeling calmer, more in control, and less consumed by food thoughts, while others notice low mood, anxiety, or emotional changes. For me? I lost

The landscape of diabetes and obesity management made a significant transformation in 2026, driven by the development of oral glucagon-like peptide-1 (GLP-1) receptor agonists. That means the idea of popular weight loss drugs, like tirzepatide and semaglutide, are now easier to swallow literally, figuratively, and financially. Traditionally administered via injection, GLP-1 therapies are now being formulated into pill forms, promising greater accessibility and adherence for p

Retatrutide is being called the “triple threat” of weight loss drugs—and it’s not even on the market yet. Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster.

Starting a GLP-1 lifestyle comes with a lot of hope and high expectations of quick weight loss and healthier habits. Those who are new to medications like Ozempic and Wegovy might be caught off guard by the nutrition challenges that come with slowed digestion. Whether it's not getting enough water, risking a calorie deficit that does more harm than good, or mismanaging nutrient needs, all the nutrition challenges can lead to new or increased side effects. Let's look at the to